<DOC>
	<DOCNO>NCT01160978</DOCNO>
	<brief_summary>The aim study investigate effect simvastatin treatment ischemia-reperfusion injury context cardiac- , lung- , kidney- , liver transplantation .</brief_summary>
	<brief_title>Donor Simvastatin Treatment Organ Transplantation</brief_title>
	<detailed_description>The study hypothesis per orally administer donor-related simvastatin treatment protects transplant organ cold ischemia-related injury ischemia-reperfusion injury . Also , potentially decrease natural immune activity , rejection activation thus improve long-term prognosis . 80 mg simvastatin administer donor circulation nasogastric tube 4-6 hour prior organ harvest . The impact donor simvastatin treatment investigate analyzed several specific blood sample biopsy take recipient various time-points perioperative postoperative phase . The randomized blind control group include heart- , lung- , kidney- , liver recipient whose organ donor receive statin medication prior organ harvest .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Heart , lung , liver kidney transplantation Preoperative statin treatment donor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Transplantation</keyword>
	<keyword>Simvastatin treatment</keyword>
	<keyword>Ischemia-reperfusion injury</keyword>
	<keyword>Lung failure</keyword>
</DOC>